Prevalence and risk factors of hearing loss in children with solid tumors treated with platinum-based chemotherapy

Journal Title: Paediatrica Indonesiana - Year 2015, Vol 55, Issue 3

Abstract

Background The platinum-based chemotherapy drugs, cisplatin and carboplatin, are widely used in the treatment of several types of solid tumors. However, the treatment has side effects including hearing loss.Objective To evaluate the prevalence of hearing loss related to platinum-based chemotherapy and to identify associated factors.Methods A cross-sectional study was performed in Adam Malik Hospital, Medan, North Sumatera, from April to July 2012. Twenty-two subjects who fulfilled the eligibility criteria underwent otoacoustic emission evaluations. Eleven children had received cisplatin and eleven had received carboplatin. The association between hearing loss and risk factors was assessed using Fisher’s exact and Chi-square tests.Results Seven subjects with hearing loss were identified. Five of these patients (5 out of 11) had received cisplatin and 2 patients (2 out of 11) had received carboplatin. There was no statistically significant difference between carboplatin- and cisplatin-associated hearing loss (P=0.361). Neither gender (P=0.452) nor age (P=0.212) was related to hearing loss. However, higher cumulative chemotherapy doses (cisplatin >600 mg/m² and carboplatin >1800 mg/m²) were associated with hearing loss (P=0.022 and P=0.004, respectively).Conclusion Patients who had higher cumulative doses of platinum-based chemotherapy are at risk for developing hearing loss.

Authors and Affiliations

Eka D Edward, Nelly Rosdiana, Farhat Farhat, Olga Siregar, Bidasari Lubis

Keywords

Related Articles

Prevalence of exclusive breastfeeding in Indonesia: a qualitative and quantitative study

Background Breast milk is the best and most ideal food for babies because it contains all nutrition needed for their optimal growth and development. Babies who receive breast milk will have strong immune s...

Correlation between lipid profile and C-reactive protein in children with nephrotic syndrome

Background Nephrotic syndrome (NS) causes dyslipidemia in children, which can be long term or intermittent. Dyslipidemia has long been established as a risk factor for atherosclerosis. An early sign of atherosclerosis is...

The role of genetic variation in TCF7L2 and KCNJ11, dietary intake, and physical activity on fasting plasma glucagon-like peptide-1 in male adolescents

Background Transcription factor 7-like 2 (TCF7L2) and potassium voltage-gated channel subfamily j member 11 (KCNJ11) gene polymorphisms have been associated with type 2 diabetes mellitus (T2DM) via regulation of insulin...

Academic achievement of junior high school students with sleep disorders

Background Sleep disorders are prevalent in adolescents and may influence their academic achievement. To date, no study has been done in Indonesia on academic achievement in students with sleep disorders and its related...

The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine

Background Haemophilus influenzae type b (Hib) causes infection with predominant manifestations of pneumonia, meningitis, and other invasive diseases, occurring primarily in children aged under 2 years, particularly in i...

Download PDF file
  • EP ID EP448536
  • DOI 10.14238/pi55.3.2015.121-5
  • Views 56
  • Downloads 0

How To Cite

Eka D Edward, Nelly Rosdiana, Farhat Farhat, Olga Siregar, Bidasari Lubis (2015). Prevalence and risk factors of hearing loss in children with solid tumors treated with platinum-based chemotherapy. Paediatrica Indonesiana, 55(3), 121-5. https://europub.co.uk./articles/-A-448536